S 
Sanofi SAN.PA · EUR
Health Care · Pharmaceuticals · Euronext Paris · 🇫🇷 France
Euro Stoxx 50
85.76
+2.41%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in EUR, from our data supplier.
Revenue
€46.72bn
FY2016FY2025
Net income
€7.81bn
FY2016FY2025
Free cash flow
€8.99bn
FY2016FY2025
Shareholders' equity
€71.38bn
FY2016FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | €46.72bn | €44.29bn | €41.11bn | €40.30bn | €39.17bn | €37.37bn | €37.63bn | €35.68bn | €36.22bn | €34.70bn |
| Gross profit | €33.67bn | €31.09bn | €28.49bn | €28.43bn | €26.92bn | €25.26bn | €25.66bn | €24.36bn | €24.77bn | €24.00bn |
| Research and development | €7.84bn | €7.39bn | €6.51bn | €6.50bn | €5.69bn | €5.53bn | €6.02bn | €6.35bn | €5.57bn | €5.23bn |
| Operating income | €9.60bn | €8.87bn | €8.12bn | €10.38bn | €8.13bn | €7.58bn | €3.05bn | €4.95bn | €5.80bn | €6.53bn |
| Net income | €7.81bn | €5.56bn | €5.40bn | €8.37bn | €6.22bn | €12.29bn | €2.75bn | €4.31bn | €8.42bn | €4.71bn |
| Diluted earnings per share | 6.44 | 4.44 | 4.31 | 6.65 | 4.96 | 9.80 | 2.20 | 3.46 | 6.72 | 3.67 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | €126.81bn | €132.80bn | €126.46bn | €124.58bn | €120.24bn | €114.53bn | €112.74bn | €111.41bn | €99.81bn | €104.67bn |
| Cash and short-term investments | €7.66bn | €7.93bn | €8.98bn | €12.74bn | €10.10bn | €13.91bn | €9.85bn | €7.12bn | €10.39bn | €10.30bn |
| Total liabilities | €55.10bn | €54.94bn | €52.11bn | €51.57bn | €51.21bn | €51.16bn | €53.63bn | €52.37bn | €41.57bn | €46.95bn |
| Debt | €20.33bn | €17.89bn | €18.44bn | €21.21bn | €22.41bn | €23.68bn | €25.93bn | €24.68bn | €15.58bn | €18.53bn |
| Shareholders' equity | €71.38bn | €77.51bn | €74.04bn | €73.14bn | €68.68bn | €63.00bn | €58.93bn | €58.88bn | €58.07bn | €57.55bn |
| Shares outstanding | 1,213m | 1,254m | 1,254m | 1,258m | 1,255m | 1,255m | 1,253m | 1,246m | 1,253m | 1,283m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | €10.75bn | €9.08bn | €10.26bn | €10.53bn | €10.52bn | €7.45bn | €7.74bn | €5.55bn | €7.38bn | €7.84bn |
| Capital spending | −€1.76bn | −€3.19bn | −€1.62bn | −€2.20bn | −€2.04bn | −€2.11bn | −€1.82bn | −€1.98bn | −€1.96bn | −€2.08bn |
| Free cash flow | €8.99bn | €5.89bn | €8.64bn | €8.32bn | €8.48bn | €5.33bn | €5.93bn | €3.57bn | €5.42bn | €5.75bn |
| Dividends paid | −€4.77bn | −€4.70bn | −€4.45bn | −€4.17bn | −€4.01bn | −€3.94bn | −€3.83bn | −€3.77bn | −€3.71bn | −€3.76bn |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | €12.30bn | €11.24bn | €11.30bn | €13.17bn | €10.73bn | €10.61bn | €11.42bn | €14.16bn |
| Gross profit | €9.28bn | €8.11bn | €16.57bn | €9.76bn | €7.74bn | €7.72bn | €7.84bn | €10.07bn |
| Operating income | €1.12bn | €2.27bn | €7.41bn | €3.79bn | €1.71bn | €2.23bn | €1.19bn | €3.63bn |
| Net income | €343.0m | €1.61bn | €2.00bn | €2.80bn | €3.94bn | €1.87bn | €683.0m | €2.81bn |
| Diluted earnings per share | 0.29 | 1.35 | 1.65 | 2.31 | 3.25 | 1.54 | 0.54 | 2.25 |
| Cash from operations | €4.64bn | €1.68bn | €7.20bn | €3.75bn | €3.56bn | €2.09bn | €7.66bn | €3.85bn |
| Capital spending | −€1.30bn | — | −€342.0m | −€845.0m | −€1.42bn | — | −€153.0m | — |
| Free cash flow | €3.35bn | — | €6.85bn | €2.90bn | €2.13bn | — | €7.50bn | — |
| Total assets | €129.06bn | €128.02bn | €126.81bn | €129.79bn | €124.96bn | €131.89bn | €132.80bn | — |
| Cash and short-term investments | €6.35bn | €5.54bn | €7.66bn | €8.91bn | €15.36bn | €7.99bn | €7.93bn | €6.79bn |
| Debt | €21.90bn | €18.48bn | €20.33bn | €21.75bn | €22.29bn | €21.05bn | €17.91bn | — |
| Shareholders' equity | €69.21bn | €72.81bn | €71.38bn | €73.26bn | €70.01bn | €74.07bn | €77.51bn | €73.00bn |
Financial ratios
Data as of 9 Sept 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Gross margin | 72.1% | 70.2% | 69.3% | 70.6% | 68.7% | 67.6% |
| Operating margin | 20.5% | 20.0% | 19.8% | 25.8% | 20.7% | 20.3% |
| Net margin | 16.7% | 12.6% | 13.1% | 20.8% | 15.9% | 32.9% |
| Return on equity | 10.9% | 7.2% | 7.3% | 11.4% | 9.1% | 19.5% |
| Return on assets | 6.2% | 4.2% | 4.3% | 6.7% | 5.2% | 10.7% |
| Free cash flow yield | 14.0% | 13.3% | 12.8% | 13.7% | 13.6% | 10.3% |
| Revenue growth | 5.5% | 7.7% | 2.0% | 2.9% | 4.8% | -0.7% |
| Earnings growth | 40.5% | 3.0% | -35.5% | 34.5% | -49.4% | 346.4% |
| Current ratio | 1.09x | 1.46x | 1.27x | 1.42x | 1.44x | 1.75x |
| Debt to equity | 0.26x | 0.21x | 0.23x | 0.26x | 0.30x | 0.36x |
| Equity ratio | 56.3% | 58.4% | 58.5% | 58.7% | 57.1% | 55.0% |
| Interest coverage | 15.33x | 14.88x | 15.56x | 26.35x | 22.45x | 16.37x |
| R&D as a share of sales | 16.8% | 16.7% | 15.8% | 16.1% | 14.5% | 14.8% |
| Buybacks as a share of market value | 3.3% | 0.0% | 0.3% | -0.2% | 0.0% | -0.2% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 5.0% | 4.6% | 3.0% |
| Operating income | -2.6% | 4.8% | 5.5% |
| Net income | -2.3% | -8.7% | 6.2% |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 71.2% | 70.6% | 69.8% | 69.3% |
| Operating margin | 20.3% | 21.4% | 21.2% | 18.4% |
| Net margin | 14.7% | 15.7% | 18.3% | 16.4% |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings | 12.8 | 21.1 | 20.8 | 13.5 | 17.9 | 8.0 | 40.8 | 21.9 | 10.7 | 20.9 |
| Price to sales | 2.1 | 2.6 | 2.7 | 2.8 | 2.8 | 2.6 | 3.0 | 2.6 | 2.5 | 2.8 |
Dividends and splits
Per share, in the currency the company pays
Paid for 26 years. Last went ex-dividend on 5 May 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|---|
| Paid in the year | 4.12 | 3.92 | 3.76 | 3.56 | 3.313 | 3.20 | 3.15 | 3.07 |
- 1-to-1 reverse split · 28 Jul 2004
- 4-for-1 split · 25 May 1999
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.